Media

Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for safe, affordable, COVID-19 vaccines and treatments, joined a national press conference on shortages of COVID-19 treatment remdesivir with Dr. Tom Patterson, Chief of Infectious Diseases at UT Health San Antonio; Dr. Rochelle Walensky, Chief of Infectious Diseases at Massachusetts General Hospital; Zain Rizvi, Law and Policy Researcher at Public Citizen; and Joe Torsella, Pennsylvania Treasurer. This press call was held in coordination with The PrEP4All Collaboration, Public Citizen, and Social Security Works.

Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for science-led development of safe, affordable, COVID-19 vaccines and treatments, reacted to Food and Drug Administration (FDA) Commissioner Stephen Hahn telling the Financial Times that “his agency was prepared to authorise a vaccine before Phase Three clinical trials were complete,” raising concerns of political interference. Rep. Doggett’s statement:

Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), sponsor of the Delivering for America Act, released the following statement on its House passage a moment ago:

Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, joined with U.S. Representative Katie Porter (D-CA), a member of the House Committee on Oversight and Reform, to press the Trump Administration for answers on how HHS is protecting the taxpayer investment in funding and procurement agreements for Moderna’s COVID-19 vaccine.